Drug Therapy

  • Shortness of breath, fever, cough, and more in an elderly woman
    Brody D. Slostad, MD, Megha Prasad, MD and Nandan S. Anavekar, MD
    Cleveland Clinic Journal of Medicine September 2018, 85 (9) 685-692; DOI: https://doi.org/10.3949/ccjm.85a.18030

    The patient’s many problems include ventricular tachycardia, requiring an implanted cardioverter-defi brillator and amiodarone.

  • Calcium and vitamin D: To supplement or not?
    Ian R. Reid, MD
    Cleveland Clinic Journal of Medicine September 2018, 85 (9) 693-698; DOI: https://doi.org/10.3949/ccjm.85a.18026

    Current evidence suggests little reason to prescribe calcium, and vitamin D should be for patients with low levels.

  • Diagnosing and treating bipolar disorder in primary care
    Parashar Koirala, MD and Amit Anand, MD
    Cleveland Clinic Journal of Medicine August 2018, 85 (8) 601-608; DOI: https://doi.org/10.3949/ccjm.85gr.18003

    Many patients have undiagnosed bipolar depression, ie, depression with shifts to periods of mania.

  • Phosphorus binders: The new and the old, and how to choose
    Phosphorus binders: The new and the old, and how to choose
    Arjun Sekar, MD, Taranpreet Kaur, MD, Joseph V. Nally, MD, Hernan Rincon-Choles, MD, Stacey Jolly, MD, MAS, FACP and Georges N. Nakhoul, MD
    Cleveland Clinic Journal of Medicine August 2018, 85 (8) 629-638; DOI: https://doi.org/10.3949/ccjm.85a.17054

    The pathophysiology and control of hyperphosphatemia in kidney disease, focusing on phosphorus binders.

  • Phosphorus in kidney disease: Culprit or bystander?
    Malvinder S. Parmar, MB, MS, FRCPC, FASN
    Cleveland Clinic Journal of Medicine August 2018, 85 (8) 639-642; DOI: https://doi.org/10.3949/ccjm.85a.18013

    As kidney function declines, phosphorus accumulates, but the process is complex.

  • What inpatient treatments do we have for acute intractable migraine?
    Ashhar S. Ali, DO and Mark Stillman, MD
    Cleveland Clinic Journal of Medicine July 2018, 85 (7) 514-516; DOI: https://doi.org/10.3949/ccjm.85a.17049

    Options: volume repletion, antiemetics, antiepileptics, NSAIDs, corticosteroids, and magnesium sulfate. Avoid opioids.

  • Navigating travel with diabetes
    Navigating travel with diabetes
    Rachael Mullin, OMS3, MS, Davida Kruger, MSN, APN-BC, BC-ADM, CNP, Clipper F. Young, PharmD, CDE, MPH, BC-ADM and Jay H. Shubrook, DO
    Cleveland Clinic Journal of Medicine July 2018, 85 (7) 537-542; DOI: https://doi.org/10.3949/ccjm.85a.17105

    Help patients plan ahead to manage diabetes while traveling and prepare for emergencies that may arise.

  • Hydroxychloroquine: An old drug with new relevance
    Eugen Alexander Shippey, MD, Vanya D. Wagler, DO, FACP, FACR and Angelique N. Collamer, MD, FACP, FACR
    Cleveland Clinic Journal of Medicine June 2018, 85 (6) 459-467; DOI: https://doi.org/10.3949/ccjm.85a.17034

    This antimalarial drug is now approved to treat discoid lupus, systemic lupus erythematosus, and rheumatoid arthritis.

  • Perioperative interruption of dual antiplatelet therapy (November 2017)
    Elias B. Hanna, MD and Eliana Hanna Deschamps, MD
    Cleveland Clinic Journal of Medicine April 2018, 85 (4) 261; DOI: https://doi.org/10.3949/ccjm.85c.04001

    Readers comment on perioperative interruption of dual antiplatelet therapy (November 2017).

  • In reply: Perioperative interruption of dual antiplatelet therapy (November 2017)
    Ryan Munyon, Steven L. Cohn, MD, FACP, SFHM, Barbara Slawski, MD, MS, SFHM, Gerald W. Smetana, MD, MACP and Kurt Pfeifer, MD, FACP, SFHM
    Cleveland Clinic Journal of Medicine April 2018, 85 (4) 262; DOI: https://doi.org/10.3949/ccjm.85c.04002

Pages